Premium
Methotrexate vs. fumaric acid esters in moderate‐to‐severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions
Author(s) -
Inzinger M.,
Weger W.,
Heschl B.,
Salmhofer W.,
Quehenberger F.,
Wolf P.
Publication year - 2013
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2012.04596.x
Subject(s) - medicine , psoriasis , methotrexate , plaque psoriasis , clinical endpoint , gastroenterology , wilcoxon signed rank test , complete remission , surgery , chemotherapy , clinical trial , dermatology , mann–whitney u test
To compare the clinical efficacy of methotrexate (MTX) vs. fumaric acid esters (FAE) in psoriasis treated under daily life conditions.